Left Ventricular Dyssynchrony in Multipole Pacing
Launched by ADNAN KASTRATI, MD · Jun 12, 2017
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
Left ventricular dyssynchrony will be assessed by echocardiography using different programming of an implantable cardioverter defibrillator using a quadripolar left ventricular lead.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Indication for the implantation of a defibrillator with cardiac resynchronisation therapy
- Exclusion Criteria:
- • Cardiac surgery, acute coronary syndrome / myocardial infarction, percutaneous coronary intervention within the past 4 weeks
- • Indication for coronary artery revascularisation
- • Atrial fibrillation with insufficient rate control
- • ASA (American Society of Anesthesiologists) class V or cardiogenic shock
- • age \<18 years, pregnancy, tutelage
- • inability to understand the patient consent for or study refusal
- • anticipated insufficient echocardiographic image quality
Trial Officials
Severin Weigand, MD
Principal Investigator
Deutsches Herzzentrum Muenchen
About Adnan Kastrati, Md
Dr. Adnan Kastrati, MD, is a distinguished clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With extensive expertise in cardiology and a focus on innovative therapeutic approaches, Dr. Kastrati leads clinical trials that explore novel treatment options and enhance understanding of cardiovascular diseases. His dedication to rigorous scientific standards and patient safety ensures that all research initiatives are conducted with the highest ethical considerations. Through collaboration with leading medical institutions and research organizations, Dr. Kastrati aims to contribute valuable insights to the medical community and facilitate the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Muenchen, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials